KRT19 and breast cancer: One of these mutant molecules, cytokeratin 19 (CK19), is differentially expressed in the peripheral blood [8,9] and lymph nodes [10] of patients with breast cancer, or in epithelial cells of CRC patients with advanced Dukes' stage [11].